HQ: San Diego, California, United States

Sorrento Therapeutics Contact Information – Key Personnel, Emails & Support Lines

sorrentotherapeutics.com

About Sorrento Therapeutics Company

Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.

Sorrento Therapeutics Specialization

Pharmaceuticals, Biotechnology, Healthcare & Medical

Sorrento Therapeutics General Information

HQ: San Diego, California, United States

Business Type: Public

Employees: 101-250

Rounds: Post-IPO Equity

Founded Date: 2006

Number of Exits: 1

Company Type: For Profit

Stock Symbol: NASDAQ:SRNE

Operating Status: Active

Last Funding Type: Post-IPO Equity

Phone Number: (858) 210-3759

Sub-Organization of: Sorrento Therapeutics

Last Investment Activity: Feb 27, 2024

Investments Activity: Feb 27, 2024 Feb 21, 2024 Jul 21, 2023

Sorrento Therapeutics Email Format

{first_letter_first_name}{last_name}@sorrentotherapeutics.com — 100.0% (example: ssmith@domain.com)

Sorrento Therapeutics General Sorrento Therapeutics Emails

  • General Inquiries

    info@sorrentotherapeutics.com

  • Admin Team

    admin@sorrentotherapeutics.com

  • Management Department

    manager@sorrentotherapeutics.com

  • Legal Department

    legal@sorrentotherapeutics.com

Contact details of 12 Sorrento Therapeutics executives

Jaisim Shah

President & Chief Executive Officer
  • Work email

    j***h@sorrentotherapeutics.com

Dean Ferrigno

Vice President Of Finance
  • Work email

    d*******o@sorrentotherapeutics.com

Ryan Tang

It Director
  • Work email

    r***g@sorrentotherapeutics.com

Dindo Sy Chu

Vice President Finance
  • Work email

    d**u@sorrentotherapeutics.com

Hua Huang

Director
  • Work email

    h****g@sorrentotherapeutics.com

Mark Brunswick

SVP Head of Regulatory Affairs and Quality
  • Work email

    m********k@sorrentotherapeutics.com

Silvia Chang

Head of Small Molecule Program Management/Executive Director Program Management
  • Work email

    s****g@sorrentotherapeutics.com

Jiong Shao

CFO, Executive VP

Robert Allen

Vice President Antiviral and oncolytic immunotherapy development

David Miao

Chief Technology Officer

Richard G. Vincent

Director, Chief Financial Officer

Henry Ji

Founder

Contact details of 4 Sorrento Therapeutics other employees

Yan Li

Senior Scientist, Antibody Technology Development
  • Work email

    y*i@sorrentotherapeutics.com

Vanessa Mendez

Quality
  • Work email

    v*****z@sorrentotherapeutics.com

Meredith Childers

Senior Writer
  • Work email

    m*******s@sorrentotherapeutics.com

Emmy Bashi

Manager, SEC Reporting,Senior Accountant

Similar Companies like Sorrento Therapeutics

HQ: North Chicago, Illinois, United States

AbbVie

abbvie.com

AbbVie is a pharmaceutical company that discovers, develops,...

HQ: North Chicago, Illinois, United States

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Debt

Last Investment Activity: Mar 22, 2024

Founded Date: 2013

Number of Exits: 3

Company Type: For Profit

Stock Symbol: NYSE:ABBV

Operating Status: Active

HQ: New York, New York, United States

Pfizer is a biopharmaceutical company that provides affordab...

HQ: New York, New York, United States

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Debt

Last Investment Activity: Sep 3, 2024

Venture Stage: Early Stage Venture, Late Stage Venture, Post-Ipo, Private Equity, Seed, Venture

Founded Date: 1849

Number of Exits: 19

Company Type: For Profit

Stock Symbol: NYSE:PFE

Operating Status: Active

Investor Type: Corporate Venture Capital, Venture Capital

HQ: Rahway, New Jersey, United States

Merck

merck.com

Merck is a biopharmaceutical company that offers medicines a...

HQ: Rahway, New Jersey, United States

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Equity

Last Investment Activity: Mar 28, 2024

Founded Date: 1891

Number of Exits: 9

Company Type: For Profit

Stock Symbol: NYSE:MRK

Operating Status: Active


Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.